Atlas Trials

Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model

Clinical trial NCT05507567 · COMPLETED

Trial details

NCT number
NCT05507567
Sponsor
Pneumagen Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Influenza Viral Infections
Start date
2022-08-12
Primary completion
2023-05-04
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.